Drug Profile
Desoximetasone topical - Taro Pharmaceuticals
Alternative Names: Desoximetasone 0.25% or 0.5% topical spray - Taro Pharmaceuticals USA; Desoximetasone topical spray - Taro Pharmaceuticals; DSXS; TopicortLatest Information Update: 08 Sep 2021
Price :
$50
*
At a glance
- Originator Medicis Pharmaceutical Corporation
- Developer Taro Pharmaceuticals USA
- Class Anti-inflammatories; Corticosteroids; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Plaque psoriasis
- No development reported Atopic dermatitis
Most Recent Events
- 08 Sep 2021 No development reported - Phase-II for Plaque psoriasis (In adolescents, In adults) in USA (Topical,Shampoo)
- 08 Sep 2021 No development reported - Phase-III for Atopic dermatitis (In adolescents, In children, In the elderly, In infants, In adults) in USA (Topical)
- 08 Sep 2021 No development reported - Phase-III for Plaque psoriasis (In adolescents, In adults) in USA (Topical,Spray)